On the other hand, a meta-analysis has shown that 173 polymorphisms are a risk factor for inflammatory bowel disease; however, due to a lack of clinical details and original data, the effect of MIF polymorphisms on disease progression and severity could not be analyzed (39). The gene discussed is MIF; the disease is inflammatory bowel disease.